没有HLA匹配测试的捐赠者细胞治疗和免疫抑制治疗
Shinya Minatoguchi1, Yasuyuki Fujita2, Kuniyasu Niizuma3,4,5,6
1Department of Cardiology, Gifu Municipal Hospital, Gifu, Japan.
Stem cells translational medicine
|April 1, 2024
概括
慕斯细胞是介质干细胞 (MSC) 的一个子集,表现出独特的再生特性. 这些多能性干细胞具有选择性定位和广泛的分化潜力,提供了新的治疗策略.
科学领域:
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
- 免疫学 免疫学 免疫学
背景情况:
- 介质细胞干细胞 (MSCs) 由于它们的类旁观者效应,在再生医学中被广泛使用.
- MSCs是一个异质的群体,Muse细胞代表着一个独特的多能类子集.
- 细胞具有独特的特征,使其与MSC区分开来.
研究的目的:
- 为了回顾Muse细胞的基本特性.
- 要突出关于Muse细胞治疗的临床前和临床发现.
- 探索Muse细胞在再生医学中的治疗潜力.
主要方法:
- 专注于临床前研究和临床试验,涉及输静脉注射捐赠者Muse细胞.
- 对Muse细胞特征的分析,包括归宿,分化和免疫耐受性.
- 与MSCs的Muse细胞属性的比较.
主要成果:
- 不同于MSCs,Muse细胞在静脉注射后选择性地安置受损组织,与MSC不同.
- 慕斯细胞可以通过细胞分裂来分化和替换广泛的受损/亡细胞.
- 慕斯细胞表现出长期的免疫耐受性,消除了对HLA匹配或免疫抑制剂的需要.
结论:
- 在治疗应用中,Muse细胞比MSCs具有独特的优势.
- 丝细胞可以解释MSC中观察到的低频,广泛的分化潜力.
- 斯细胞利用在再生医学中为临床治疗提供了一种新的策略.
关键词:
骨髓缩侧面硬化症 (ALS) 是一种皮肤表面溶解牛皮质.免疫耐受性 免疫耐受性静脉内注射的注射是静脉内注射.心肌梗塞的心脏病发作具有多能性的多能性.斯芬戈-1-酸盐是一种酸盐.一次性中风中风中风中风中风更多相关视频
10:29Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
15.7K
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
相关概念视频
01:24Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
01:22Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328